When did Gyre Therapeutics, Inc. report Q4 2024 earnings?

Gyre Therapeutics, Inc. (GYRE) reported Q4 2024 earnings on March 17, 2025 before market open.

What were Gyre Therapeutics, Inc.'s Q4 2024 revenue and EPS?

Gyre Therapeutics, Inc. reported revenue of $27.9M and eps of $0.01 for Q4 2024.

Did Gyre Therapeutics, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $23.5M by $4.4M. EPS missed the consensus estimate of $0.04 by $0.03.

Where can I find Gyre Therapeutics, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-040279) directly on SEC EDGAR. The filing index links above go to sec.gov.

Gyre Therapeutics, Inc. GYRE Q4 2024 Annual earnings

Reported March 17, 2025 · Before market open

Revenue$27.9MBeat by $4.4M

EPS$0.01Miss by $0.03

Revenue estimate$23.5M

EPS estimate$0.04

Next report

Aug 10, 2026 (In 1 week)

Revenue estimate$26.5M

EPS estimate-$0.08

Financials

Q4 2024

Income statement

See full

Revenue$27.9M+2.7%

Gross profit$26.7M+3.1%

Operating income$665.0K+101%

Net income-+100%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$11.8M-64.7%

Total debt$1.6M+291%

Total equity$63.3M+500%

Total assets$125.4M+7.6%

Cash flow

See full

Operating cash flow-$2.8M-182%

CapEx--100%

Free cash flow-$2.7M-360%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.04B-47.2%

Enterprise value$1.03B-46.8%

P/E85.2×—

P/S9.8×-7.5×

Profitability

See full

Gross margin96.3%+0.4pp

Operating margin15.3%+8.5pp

Net margin11.5%+6.1pp

Returns & leverage

See full

Debt / equity0×—

Current ratio3.3×+0.5×

Segments

By segment

See full

Gyre Pharmaceuticals$27.9M+2.7%

By product

See full

Other Product$153.0K—

Versus estimates

Revenue

Q1 2026$22.5MMiss by $9.1M Q4 2025$37.2MBeat by $1.8M Q3 2025$30.6MMiss by $5.7M Q2 2025$26.8MMiss by $7.5M Q1 2025$22.1MMiss by $6.6M

Q4 2024$27.9MBeat by $4.4M

Diluted EPS

Q1 2026-$0.05Beat by $0.01 Q4 2025$0.04Miss by $0.02 Q3 2025$0.06Beat by $0.01 Q2 2025$0.02Miss by $0.01 Q1 2025$0.03In line

Q4 2024$0.01Miss by $0.03

Ask the moment Gyre Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Gyre Therapeutics, Inc. report Q4 2024 earnings?: Gyre Therapeutics, Inc. (GYRE) reported Q4 2024 earnings on March 17, 2025 before market open.
What were Gyre Therapeutics, Inc.'s Q4 2024 revenue and EPS?: Gyre Therapeutics, Inc. reported revenue of $27.9M and eps of $0.01 for Q4 2024.
Did Gyre Therapeutics, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $23.5M by $4.4M. EPS missed the consensus estimate of $0.04 by $0.03.
Where can I find Gyre Therapeutics, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-040279) directly on SEC EDGAR. The filing index links above go to sec.gov.